Scott Moore explores China’s trajectory in the global biotechnology sector. When America continues to be the dominant international player in acquiring and commercializing biotechnology for decades, China is set to be a number one participant in biotechnology and is investing intensely while in the sector. Moore argues that, though the U.S. is pr